BRAF and nodular malignant melanoma: For instance, convolutional neural networks can be applied to hematoxylin and eosin slides and then paired with mutational status information like BRAF V600E or NRAS Q61 to distinguish between biologically distinct subsets of superficial spreading and nodular melanoma [43].